AI assistant
Sending…
AGILYSYS INC — Director's Dealing 2023
Jan 31, 2023
31401_dirs_2023-01-31_9bdf483f-958d-40a9-9eb6-b24a0a1a9016.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGILYSYS INC (AGYS)
CIK: 0000078749
Period of Report: 2023-01-27
Reporting Person: Wood William David III (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-01-27 | Common Stock | M | 4640 | $0.00 | Acquired | 41981 | Direct |
| 2023-01-27 | Common Stock | M | 997 | $0.00 | Acquired | 42978 | Direct |
| 2023-01-27 | Common Stock | M | 39087 | $0.00 | Acquired | 82065 | Direct |
| 2023-01-27 | Common Stock | M | 14325 | $0.00 | Acquired | 96390 | Direct |
| 2023-01-27 | Common Stock | F | 32292 | $83.02 | Disposed | 64098 | Direct |
| 2023-01-27 | Common Stock | S | 6000 | $83.94 | Disposed | 58098 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-01-27 | Stock-Settled Appreciation Rights | $11.96 | M | 4640 | Disposed | 2024-11-03 | Common Stock (4640) | Direct |
| 2023-01-27 | Stock-Settled Appreciation Rights | $14.22 | M | 997 | Disposed | 2025-05-31 | Common Stock (997) | Direct |
| 2023-01-27 | Stock-Settled Appreciation Rights | $20.02 | M | 39087 | Disposed | 2027-11-19 | Common Stock (39087) | Direct |
| 2023-01-27 | Stock-Settled Appreciation Rights | $20.02 | M | 14325 | Disposed | 2027-11-19 | Common Stock (2528) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.12 to $85.66. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F2: Grant has a graded vesting schedule. Date Exercisable will vary for each vesting tranche.
More from AGILYSYS INC
Annual Report
2026
May 21
Regulatory Filings
2026
May 18
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 3
Investor Presentation
2026
Feb 2
Interim / Quarterly Report
2026
Jan 26
Regulatory Filings
2026
Jan 26
Director's Dealing
2025
Dec 29
Investor Presentation
2025
Dec 16
Director's Dealing
2025
Nov 25